Manorama Industries Q1 FY27: Revenue ₹404 Cr, PAT ₹79 Cr
Manorama Industries Ltd
MANORAMA
Ask Iris
The headline numbers from Q1 FY27
Manorama Industries Limited (NSE: MANORAMA) reported a strong start to FY27, with Q1 results showing sharp year-on-year growth across revenue, operating profit, and net profit. The company crossed the ₹4,000 million quarterly revenue milestone for the first time, taking consolidated revenue to ₹404.0 crore for the quarter. Management attributed the performance to a richer product mix of value-added offerings and higher traction from expanded fractionation capacity.
The earnings call for the quarter was held on August 14, 2026, covering the period ended June 30, 2026. Alongside financial performance, the company also outlined a proposed capital expenditure plan of ₹460 crore, including a Burkina Faso facility allocation of about ₹120-130 crore. The remainder of the CapEx is planned for Indian projects.
Revenue growth: export strength and domestic demand
Consolidated revenue for Q1 FY27 stood at ₹404.0 crore, up 39.5% year on year from ₹289.6 crore in Q1 FY26. The company also disclosed that revenue from operations was ₹404.0 crore in Q1 FY27 compared to ₹289.6 crore in Q1 FY26. On a sequential basis, revenue from operations rose 3.24% over Q4 FY26.
Manorama Industries reported an export-to-domestic revenue mix of 60:40 for the quarter. The mix indicates exports remain the larger contributor, while domestic demand stayed healthy. Management linked the revenue increase to a better product mix and higher utilisation of expanded fractionation capacity.
Operating performance: EBITDA rises, margins inch up
EBITDA for Q1 FY27 increased to ₹106.2 crore, compared with ₹74.7 crore in Q1 FY26, a year-on-year rise of 42.2%. EBITDA margin expanded to 26.3% from 25.8%, an improvement of 49 basis points.
The company attributed the margin expansion to disciplined cost management, operational efficiencies, and operating leverage. The quarter also marked an “EBITDA milestone” alongside the revenue crossing, as mentioned in the management commentary.
Net profit and EPS: PAT up 67.6%
Profit after tax (PAT) climbed to ₹78.7 crore in Q1 FY27 from ₹46.9 crore in Q1 FY26, representing 67.6% growth year on year. PAT margin widened to 19.5% from 16.2%, an expansion of 326 basis points.
Diluted EPS for Q1 FY27 was reported at ₹13.17 compared with ₹7.85 in Q1 FY26, up 67.8% year on year. The company also noted basic and diluted EPS (before extraordinary items) at ₹13.17 for the quarter.
Gross margin slips despite higher profits
While EBITDA and PAT margins improved, consolidated gross profit margin declined. The gross margin stood at 43.6% in Q1 FY27 versus 47.4% in Q1 FY26, a drop of 376 basis points.
The transcript summary also references gross profit of ₹100 crore for Q1 FY27 and ₹68 crore for Q1 FY26. Despite this increase in absolute gross profit, the margin compression suggests cost of goods sold rose faster than revenue in percentage terms during the quarter.
Other income and balance sheet cues from QIP
Other income for the quarter was ₹16.2 crore, including ₹13.0 crore in forex gains and ₹3.0 crore from fixed deposit interest. The transcript summary linked this to a strengthened balance sheet after the company’s ₹500 crore qualified institutional placement (QIP) completed in July 2026.
While the quarter’s operating results were the main driver of profit growth, the disclosure on other income provides context on treasury gains and foreign exchange movements in the period.
CapEx plan: ₹460 crore, Burkina Faso allocation defined
The company outlined a total proposed CapEx plan of ₹460 crore. Of this, the Burkina Faso facility is expected to account for around ₹120-130 crore. The balance amount is planned for Indian projects.
This split indicates the company is pursuing both overseas and domestic capacity or capability additions, with the Burkina Faso investment clearly ring-fenced within the broader CapEx envelope, as per the disclosed plan.
Key financial snapshot table
CapEx allocation table (as disclosed)
Market snapshot and disclosed stock reference
A results note in the provided text referenced a CMP (current market price) of ₹1,614.1, down 0.73%. The same note reiterated the quarter’s key performance metrics: revenue of ₹404 crore and consolidated PAT of ₹78 crore.
This price reference is presented alongside the results summary in the provided material, but without additional trading-day context beyond the cited CMP and percent move.
Why the update matters for investors tracking specialty fats
The quarter shows Manorama Industries delivering strong top-line growth and a faster rise in net profit, helped by operating leverage and cost management, even as gross margin declined. The export-heavy 60:40 mix underscores the company’s reliance on global demand while still maintaining domestic participation.
The defined CapEx plan of ₹460 crore, including a ₹120-130 crore allocation to Burkina Faso, adds a forward operational marker investors may track for execution. Alongside the July 2026 ₹500 crore QIP referenced in the summary, the disclosures also provide context on funding capacity and near-term balance sheet strength.
Conclusion
Manorama Industries’ Q1 FY27 performance combined 39.5% revenue growth with 42.2% EBITDA growth and a 67.6% jump in PAT, while gross margins moderated year on year. The next set of company updates investors may watch are progress markers on the ₹460 crore CapEx plan, including the ₹120-130 crore Burkina Faso facility allocation and the balance earmarked for Indian projects.
Frequently Asked Questions
Did your stocks survive the war?
See what broke. See what stood.
Live Q1 Earnings Tracker
